Parkinson's disease is a common and severe neurodegenerative disorder. Although dopamine substitution therapy or deep brain stimulation can achieve considerable improvement of quality of life for…
Clinician Scientist (m/w/d) in der Sektion „Klinische Neurogenetik“ Das Hertie-Institut für klinische Hirnforschung (HIH) bildet gemeinsam mit der Neurologischen Klinik des Universitätsklinikums…
Clinician Scientist (m/w/d) zur Mitarbeit an unserer Initiative „DefeatPD“ Das Hertie-Institut für klinische Hirnforschung (HIH) bildet gemeinsam mit der Neurologischen Klinik des…
Julia Fitzgerald is a group leader at the Hertie-Institute for Clinical Brain Research, Tübingen working on the biological processes underlying neuronal cell death in Parkinson’s disease. Using…
PD Dr. Justus Marquetand (Department Neural Dynamics and Magnetoencephalography and Department Neurology and Epileptology) was awarded the 2nd prize of the Felix Jerusalem Prize at the DMG Congress…
For the first time since the beginning of the pandemic, the Neuroscience Student Lab held a teacher training course last week. HIH researchers informed teachers about current research topics in…
In most cases, the disease is far advanced when it is diagnosed – despite first warning signs years before. This is what HIH scientist Dr. Kathrin Brockmann reports in the SWR program "Doc…
This week is Brain Awareness Week. The Hertie Foundation spoke with a family in which two sons suffer from the rare neurological hereditary disease PCH-2. The report makes clear why clinical brain…
The goal of our research is to link the molecular mechanisms of mainly genetic, neurological diseases caused by disturbed neuronal excitability to their clinical symptoms and a personalized…
